Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02718833
Title A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02115 United States Details
Mass General/North Shore Cancer Center Danvers Massachusetts 01923 United States Details
Newton-Wellesley Hospital Newton Massachusetts 02462 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
University of Rochester Rochester New York 14642 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field